[Podcast] Partner for Progress: Strategies for Biotech Success

Published on April 24, 2024

In this three-part podcast series, hear from seasoned experts from Allucent as they discuss a range of topics, including how small and mid-sized companies can take a more strategic approach to pharmacovigilance, a regulatory & development roadmap for antibody drug conjugates (ADCs) and radionuclide drug conjugates (RDCs), and the use of artificial intelligence in clinical trials and Good Clinical Practice (GCP) compliance.

Check out the podcast episodes below.

⬆

  1. Ep. 1 Strategic Alliances in the Development and Execution of Pharmacovigilance Strategy

Ep. 1

Strategic Alliances in the Development and Execution of Pharmacovigilance Strategy

In this inaugural episode of Partner for Progress: Strategies for Biotech Success, Ian Kovacs, the Global Head of Pharmacovigilance at Allucent discusses how small & mid-sized companies can efficiently manage pharmacovigilance. We’ll discuss why partnering early is key to your pharmacovigilance strategy – and to delivering products to the patients who need them.

Continue reading on website
Other news

New AI drug discovery powerhouse Xaira rises with $1B in funding

April 24, 2024
If you asked an AI to generate a brand-new drug discovery biotech with a team of some of the biggest names in the biz for you, it couldn’t dream up one like Xaira Therapeutics.The company emerged Tuesday with $1 billion in committed funding—that’s billion with a B—incubated by Arch Venture Partners and Foresite Labs with none other than Marc Tessier-Lavigne, Ph.D., former chief scientific officer

Moderna turns to AI to change how its employees work

April 24, 2024
Moderna is betting big on bespoke artificial intelligence assistants. The biotechnology company on Wednesday said it has expanded a partnership with OpenAI, the buzzy creator of ChatGPT, to give its thousands of employees access to custom-built AI chatbots.Moderna hopes these tailored versions of the AI tool that made OpenAI famous will help boost its employees’ productivity as it attempts to brin